Induction chemotherapy and larynx preservation: Is such attitude daily useful?;Chimiothérapie d'induction et préservation laryngée: Qu'en est-il en pratique?

Bulletin du Cancer

Volumn 89, Issue 4, 2002, Pages 411-417

  Sarini, Jérôme ^a   Bocciolini, Corso ^a   Fournier, Charles ^a   Penel, Nicolas ^a   Kara, Ahmed ^a   Ton Van, Jean ^a   Lefebvre, Jean Louis ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Cancer; Induction chemotherapy; Larynx preservation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0036082173     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer
2. Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancers
3. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
4. Larynx preservation in sinus piriforme cancer: Preliminary results of EORTC phase III trial
5. Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas
6. Reponse and toxicity of cisplatin and 120-h 5-fluorouracil infusion in pretreated and untreated patients with advanced apidermoid cancer of the head and neck
7. A randomized trial of cisplatine + 5 fluoro-uracile infusion and CDDP + 5 FU bolus for recurrent and advanced squamous cell carcinoma of head and neck
8. The management of the clinically positive neck as part of a larynx preservation approach
9. Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of head and neck
10. La chimiothérapie dans le traitement des cancers de l'hypopharynx
11. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M D Anderson cancer center experience
12. Randomized trial of induction chemotherapy in larynx carcinoma
13. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer
14. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5 FU infusion and cisplatin
15. Treatement of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
16. Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck
17. Concomitant BID radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: Clinical and pharmacological data of a french multicenter phase II study
18. Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer
19. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients
20. Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: Results of EORTC phase III trial 22931
21. Risk factors for wound infection in head and neck cancer surgery: A prospective study